This post includes a summary of a study published in The Lancet, Volume 375, Issue 9716, Pages 735 - 742, 27 February 2010
Study title and authors:
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Prof Naveed Sattar PhD, Dr David Preiss MRCP, Heather M Murray MSc, Paul Welsh PhD, Prof Brendan M Buckley FRCPI, Anton JM de Craen PhD, Sreenivasa Rao Kondapally Seshasai MD
This study can be accessed at: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61965-6/fulltext
Prof Naveed Sattar PhD, Dr David Preiss MRCP, Heather M Murray MSc, Paul Welsh PhD, Prof Brendan M Buckley FRCPI, Anton JM de Craen PhD, Sreenivasa Rao Kondapally Seshasai MD
This study can be accessed at: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61965-6/fulltext
An analysis of 13 statin trials with 91,140 participants investigated the effects of statin treatment on diabetes.
The study revealed:
(a) Statin therapy was associated with a 9% increased risk for diabetes.
(b) The risk of development of diabetes with statins was highest in older people.
Links to other studies:
